IMPEDIMED LIMITED — Director's Dealing 2009

Jul 5, 2009

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity	IMPEDIMED LIMITED
ABN	65 089 705 144

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Dr Michael Panaccio
Date of last notice	06/04/2009

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Indirect - Masto Pty Ltd (a company controlled by Dr Michael Panaccio): Indirect - Starfish Technology Fund 1, LP (an entity controlled by Dr Michael Panaccio): Indirect - Various holders (deemed relevant interest under section 608(3)(b) of the Corporations Act in shares which are subject to voluntary and mandatory escrow agreements with the entity:
Date of change	2ndJuly 2009

• See chapter for defined terms.

Appendix 3Y Page 1

11/3/2002

https://Portal.impedimed.com/docs/05 Corporate IR/ASX/Directors Interests/2009-07-06 Change to Directors Interest Notice - Michael Panaccio.doc

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Masto Pty Ltd (a company controlled by Dr Michael Panaccio):  229,000 ordinary shares  114,500 options to subscribe for ordinary shares at an exercise price of $0.72 per share Starfish Technology Fund 1, LP (an entity controlled by Dr Michael Panaccio):  24,285,465 ordinary shares  2,763,200 options to subscribe for ordinary shares at an exercise price of $0.72 per share Various holders (deemed relevant interest under section 608(3)(b) of the Corporations Act in shares which are subject to voluntary and mandatory escrow agreements with the entity:  8,988,386 ordinary shares (Refer Annexure A, for remaining relevant interests post the reduction in relevant interests)
Class	Ordinary shares
Number acquired	Masto Pty Ltd 25,445
Number disposed
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Masto Pty Ltd $16,284.80 (64 cents per share)

• See chapter for defined terms.

Appendix 3Y Page 2

11/3/2002

https://Portal.impedimed.com/docs/05 Corporate IR/ASX/Directors Interests/2009-07-06 Change to Directors Interest Notice - Michael Panaccio.doc

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

Masto Pty Ltd (a company controlled by Dr Michael Panaccio):  254,445 ordinary shares  114,500 options to subscribe for ordinary shares at an exercise price of $0.72 per share Starfish Technology Fund 1, LP (an entity controlled by Dr Michael Panaccio):  24,285,465 ordinary shares  2,763,200 options to subscribe for ordinary shares at an exercise price of $0.72 per share Various holders (deemed relevant interest under section 608(3)(b) of the Corporations Act in shares which are subject to voluntary and mandatory escrow agreements with the entity:  8,988,386 ordinary shares (Refer Annexure A, for remaining relevant interests post the reduction in relevant interests)

Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back

Subscription under entitlement offer dated 28thMay 2009.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder (if issued securities)	N/A
Date of change	N/A
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed	N/A
Interest acquired	N/A

• See chapter for defined terms.

Appendix 3Y Page 3

11/3/2002

https://Portal.impedimed.com/docs/05 Corporate IR/ASX/Directors Interests/2009-07-06 Change to Directors Interest Notice - Michael Panaccio.doc

Appendix 3Y Change of Director’s Interest Notice

Interest disposed	N/A
Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation	N/A
Interest after change	N/A

• See chapter for defined terms.

Appendix 3Y Page 4

11/3/2002

https://Portal.impedimed.com/docs/05 Corporate IR/ASX/Directors Interests/2009-07-06 Change to Directors Interest Notice - Michael Panaccio.doc

Appendix 3Y Change of Director’s Interest Notice

Annexure A

Name of entity	IMPEDIMED LIMITED
ABN	65 089 705 144

Deemed relevant interests in escrowed securities

	Name of holder & nature of interest Note: Provide details of the circumstances giving rise to the relevant interest. Candlegrove Pty Ltd Cherrell Hirst Colin Frederick & Lynette Anne Brown Greg Brown Klemzig Pty Ltd Melvyn Bridges Parma Corporation Pty Ltd Biophys Pty Ltd ACN 111 517 956 Roxanne Pty Ltd ACN 110 755 345 Total	Number & class of Securities 16,331 ordinary shares 69,826 ordinary shares 6,364 ordinary shares 3,123,324 ordinary shares 86,791 ordinary shares 69,826 ordinary shares 4,137,664 ordinary shares 739,130 ordinary shares 739,130 ordinary shares
		8,988,386 ordinary shares

• See chapter for defined terms.

Appendix 3Y Page 5

11/3/2002 Appendix 3Y Page 5 https://Portal.impedimed.com/docs/05 Corporate IR/ASX/Directors Interests/2009-07-06 Change to Directors Interest Notice - Michael Panaccio.doc